NCT05168917: A trial that was reported late by DiaSorin Inc.
This trial has reported, although it was 370 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT05168917 |
|---|---|
| Title | EURECA (EUropeanRElapseCAlprotectin) Study - Calprotectin as Prediction Marker of Relapse in Patients With Quiescent Ulcerative Colitis |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 2, 2017 |
| Completion date | Jan. 13, 2020 |
| Required reporting date | Jan. 13, 2021, midnight |
| Actual reporting date | Jan. 18, 2022 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 370 |